Roundview Capital’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,260
Closed -$388K 312
2023
Q2
$388K Hold
8,260
0.04% 256
2023
Q1
$347K Hold
8,260
0.04% 264
2022
Q4
$315K Buy
+8,260
New +$315K 0.04% 253